Literature DB >> 10723070

Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions.

Q Hu1, L W Jin, M Y Starbuck, G M Martin.   

Abstract

FE65 is a key "adapter" protein that links a multiprotein complex to an intracellular domain of beta-amyloid precursor protein (betaPP). Its overexpression modulates the trafficking of betaPP and facilitates the generation of beta-amyloid (Abeta). FE65 is predominantly expressed in brain tissues. An exon 9-inclusive isoform is exclusively expressed in neurons, and an exon 9-exclusive isoform is only expressed in non-neuronal cells. We quantitated the two isoforms in middle temporal cortex, middle frontal cortex, cerebellar cortex and caudate nucleus of 17 Alzheimer disease (AD) patients, 12 normal controls and 9 non-AD neurodegenerative disease controls by reverse transcription-competitive polymerase chain reaction (RT-cPCR). Expression of the two isoforms was significantly and differentially altered, with a 30-57% decrease in levels of the neuronal form (P < 0.05-0.002) and a 73-135% increase in levels of non-neuronal form (P < 0.02-0.001), in the temporal and frontal cortex of AD brains. These alterations presumably reflect advanced neurodegenerative processes of these regions. Surprisingly, expression of both isoforms was significantly up-regulated by 42-66% in the cerebellar cortex and caudate nucleus of AD brains when compared to normal brains (P < 0.05-0.005). Diffuse Abeta-positive plaques were observed in the cerebellum of these AD subjects but not in the normal controls. Selective up-regulation of only the FE65 neuronal isoform was seen in the cerebellar cortex in association with other neurodegenerative diseases (largely Parkinson's disease). Because FE65 modulates trafficking of betaPP toward the production of Abeta, the up-regulation of FE65 in AD cerebellum may be relevant to the genesis of diffuse plaques. Thus, early biochemical alterations in AD, not complicated by advanced pathology, may be beneficially investigated in the less-affected regions of the brain, such as the cerebellum. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10723070     DOI: 10.1002/(SICI)1097-4547(20000401)60:1<73::AID-JNR8>3.0.CO;2-S

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

1.  Real-time PCR quantitation of FE65 a beta-amyloid precursor protein-binding protein after traumatic brain injury in rats.

Authors:  Morio Iino; Masato Nakatome; Yoshiaki Ogura; Harutoshi Fujimura; Hisanaga Kuroki; Hiromasa Inoue; Yukiko Ino; Tasuku Fujii; Toshiyuki Terao; Ryoji Matoba
Journal:  Int J Legal Med       Date:  2003-04-18       Impact factor: 2.686

Review 2.  Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies.

Authors:  George M Martin
Journal:  Mech Ageing Dev       Date:  2011-09-22       Impact factor: 5.432

3.  A macromolecular complex involving the amyloid precursor protein (APP) and the cytosolic adapter FE65 is a negative regulator of axon branching.

Authors:  Annat F Ikin; Shasta L Sabo; Lorene M Lanier; Joseph D Buxbaum
Journal:  Mol Cell Neurosci       Date:  2007-02-08       Impact factor: 4.314

4.  FE65 in Alzheimer's disease: neuronal distribution and association with neurofibrillary tangles.

Authors:  B Delatour; L Mercken; K H El Hachimi; M A Colle; L Pradier; C Duyckaerts
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  Effects of Aroma Foot Massage on Sleep Quality and Constipation Relief among the Older Adults Living in Residential Nursing Facilities.

Authors:  Jung-In Kang; Eun-Hye Lee; Hyeon-Young Kim
Journal:  Int J Environ Res Public Health       Date:  2022-05-04       Impact factor: 4.614

6.  A flanking gene problem leads to the discovery of a Gprc5b splice variant predominantly expressed in C57Bl/6J mouse brain and in maturing neurons.

Authors:  Bethany H Cool; Guy C-K Chan; Lin Lee; Junko Oshima; George M Martin; Qubai Hu
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

Review 7.  Cytoplasmic tail adaptors of Alzheimer's amyloid-beta protein precursor.

Authors:  Masaoki Kawasumi; Shuji Matsuda; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

8.  Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.

Authors:  Mohammed Ragab Abdel-Aziz Ali; Amira Morad Hussein Abo-Youssef; Basim Anwar Shehata Messiha; Mahmoud Mohamed Khattab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-30       Impact factor: 3.000

9.  The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease?

Authors:  Daniel A Bórquez; Christian González-Billault
Journal:  Int J Alzheimers Dis       Date:  2012-02-09

10.  Total body 100-mGy X-irradiation does not induce Alzheimer's disease-like pathogenesis or memory impairment in mice.

Authors:  Bing Wang; Kaoru Tanaka; Bin Ji; Maiko Ono; Yaqun Fang; Yasuharu Ninomiya; Kouichi Maruyama; Nakako Izumi-Nakajima; Nasrin Begum; Makoto Higuchi; Akira Fujimori; Yoshihiko Uehara; Tetsuo Nakajima; Tetsuya Suhara; Tetsuya Ono; Mitsuru Nenoi
Journal:  J Radiat Res       Date:  2013-08-01       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.